As of 2025-07-09, the Intrinsic Value of Vor Biopharma Inc (VOR) is -7.98 USD. This VOR valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.40 USD, the upside of Vor Biopharma Inc is -432.67%.
Based on its market price of 2.40 USD and our intrinsic valuation, Vor Biopharma Inc (VOR) is overvalued by 432.67%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.98 - -7.98 | -7.98 | -432.67% |
| P/E | (29.51) - (41.83) | (30.14) | -1355.6% |
| DDM - Stable | (19.42) - (89.78) | (54.60) | -2374.9% |
| DDM - Multi | (0.30) - (1.06) | (0.47) | -119.4% |
| Market Cap (mil) | 127.51 |
| Beta | 5.49 |
| Outstanding shares (mil) | 53.13 |
| Enterprise Value (mil) | 77.46 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.14% |
| Cost of Debt | 5.00% |
| WACC | 6.41% |